Wednesday, July 8, 2026

pharma · HIV Infections · Major Depressive Disorder · PRAX

Praxis Precision Medicines

Praxis Precision Medicines is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker PRAX. Primary therapeutic focus areas include HIV Infections, Major Depressive Disorder, Pancreatic Cancer,

Boston, USA HQ
205 Employees
Public company Type
PRAX · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Employees
205
Programs
7
Drugs
8
Patents
35
Clinical program

Transcutaneous Cervical Spinal Cord Stimulation

Phase 3 · other · Spinal Cord Injury Cervical

Transcutaneous Cervical Spinal Cord Stimulation for Spinal Cord Injury Cervical is a Phase 3 program (other) at Praxis Precision Medicines with 1 ClinicalTrials.gov record(s).

Internal code Pro00149698

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Praxis Precision Medicines
Phase
Phase 3
Modality
other
Indication
Spinal Cord Injury Cervical
Status
active
Trials
1

Clinical trials